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Abstract
Heterotopic gastric mucosa (HGM) is characterized by islands of gastric columnar epithelium and is regarded as a con-
genital condition. The prevalence is estimated to be approximately 0.1–10%. Although most affected patients are
asymptomatic, HGM could clinically manifest with globus sensation, acid taste, dysphagia, and regurgitation. In addition,
HGM could rarely be the origin of malignant progression to esophageal adenocarcinoma. In this article, the video focuses
on the technique and application of advanced endoscopic imaging for the characterization of HGM in the esophagus,
including dye-based and dye-less chromoendoscopy. This article is part of an expert video encyclopedia.
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Video Related to this Article
Video available to view or download at doi:
Techniques
White light endoscopy; virtual chromoendoscopy (FICE); and
Lugol’s iodine staining (3%).
Endoscope
EG-530; Fujiﬁlm, Tokyo, Japan.
Background and Endoscopic Procedure
Heterotopic gastric mucosa (HGM) (synonym ‘gastric inlet
patch’) of the cervical esophagus is characterized by islands of
gastric columnar epithelium and is regarded as a congenital
condition. The prevalence is estimated to be approximately
0.1–10%.1,2 Although most affected patients are asymptom-
atic, HGM could clinically manifest with globus sensation,
acid taste, dysphagia, and regurgitation. In addition, HGM
could rarely be the origin of malignant progression to
esophageal adenocarcinoma.3
Most islands of HGM are located in the cervical esophagus,
predominantly immediately below the upper esophageal
sphincter, and could therefore easily be missed if the endo-
scope withdrawal is too fast.
Histologically, HGM is mostly of fundic type containing
acid-producing parietal cells.3 Previously it was shown that
HGM can produce a signiﬁcant amount of acid.4 Accordingly,
HGM is often accompanied by esophagitis of the adjacent
esophageal squamous epithelium. Chronic inﬂammation of
the esophageal tissue may also result in esophageal ulceration
and stricture formation. Interestingly, Helicobacter pylori could
colonize HGM. In this context, it was shown that H. pylori
colonization of HGM has a prevalence of approximately 73%
in patients with coincident H. pylori gastritis.5 However, no
correlation between H. pylori infection of HGM and acute or
chronic inﬂammation within the HGM patches was found.6
Recently, von Rahden and coworkers proposed a clin-
icopathologic classiﬁcation of esophageal HGM.3
• Type I: asymptomatic.
• Type II: symptomatic without morphological changes.
• Type III: symptomatic with morphological changes.
• Type IV: intraepithelial neoplasia.
• Type V: invasive adenocarcinoma.
Although patients with Type-I HGM do not require a speciﬁc
therapy, it is recommended to treat symptomatic patients with
proton pump inhibitors, which should result in complete
symptom resolution.3 In case of ongoing symptoms, the Mein-
ing group recently introduced an interesting novel endoscopic
approach for treatment of HGM. In these cases, argon plasma
coagulation (APC) (Erbe APC 300, 60 W, argon ﬂow 2 l min1)
was used to ablate HGM. Ablation therapy appeared to be an
effective therapy for alleviation of associated globus sensation.7,8
Key Learning Points/Tips and Tricks
• Care should be taken during withdrawal of the endoscope,
as HGM mostly occurs directly below the upper esophageal
sphincter.
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
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• Asymptomatic patients do not require a speciﬁc therapy,
although symptomatic patients should be treated with
proton pump inhibitors. APC ablation of HGM was
recently introduced as a novel endoscopic modality to
treat HGM.
• Lugol’s iodine staining improves the detection of HGM, as
iodine stains normal esophageal epithelium brown and
HGM is excluded from the brownish colorization.
Scripted Voiceover
Starting time (min:sec) Voiceover text
00:04 This female patient suffers from
regurgitation, heartburn, and severe
cough. White-light endoscopy reveals an
island of heterotopic gastric mucosa at
the 6 o’clock position.
00:18 Virtual chromoendoscopy using FICE
enables an increased demarcation of the
gastric inlet patch to the surrounding
esophageal squamous epithelium.
00:35 Dye-based chromoendoscopy with
Lugol’s solution stains normal
esophageal epithelium brown, while
heterotopic gastric mucosa is not
stained, thereby enabling exact
demarcation of the gastric inlet patch to
the surrounding esophageal tissue. To
exclude dysplasia, biopsies should be
taken from the central part of the lesion
and from any macroscopic suspect area.
00:50 This patient is submitted to our
endoscopy unit because of recurrent
cough and severe dysphagia.
Subsequent to esophageal intubation a
ﬁbrinous lesion is visible at the 3 o’clock
position. Water is inﬂated by using the
water ﬂush of the endoscope we remove
the ﬁbrinous excudates from the
mucosal surface.
01:05 An island of heterotopic gastric mucosa
becomes visible in the lower left part of
the endoscopic image.
01:14 After air insufﬂation the lumen opens wide
and another inlet patch at the upper part
of the endoscopic image becomes
obvious. One can clearly recognize a
peptic stricture caused by the acid
producing heterotopic gastric mucosa.
The stricture was dilated using Savary
bougies up to 17 mm and the patient
was put on oral acid suppressive
therapy 40 mg BID.
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